Janus Henderson Group PLC Ardelyx, Inc. Transaction History
Janus Henderson Group PLC
- $187 Billion
- Q3 2024
A detailed history of Janus Henderson Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 21,529,880 shares of ARDX stock, worth $103 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
21,529,880
Previous 25,949,323
17.03%
Holding current value
$103 Million
Previous $192 Million
22.85%
% of portfolio
0.08%
Previous 0.11%
Shares
13 transactions
Others Institutions Holding ARDX
# of Institutions
218Shares Held
141MCall Options Held
1.08MPut Options Held
2M-
Black Rock Inc. New York, NY17.6MShares$84.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$65.3 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$58.3 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C38.95MShares$43 Million0.07% of portfolio
-
Eventide Asset Management, LLC Boston, MA7.41MShares$35.6 Million0.9% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $742M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...